Cost-Effectiveness Analysis of Pharmaceutical Care in a Medicare Drug Benefit Program
- 31 August 2003
- journal article
- Published by Elsevier in Value in Health
- Vol. 6 (4) , 425-435
- https://doi.org/10.1046/j.1524-4733.2003.64255.x
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Drug-Related Morbidity and Mortality: Updating the Cost-of-Illness ModelPublished by Elsevier ,2016
- Pharmaceutical Care in Chain Pharmacies: Beliefs and Attitudes of Pharmacists and PatientsJournal of the American Pharmaceutical Association, 2001
- Potentially Inappropriate Medication Use in a Medicare Managed Care Population: Association with Higher Costs and UtilizationJournal of Managed Care Pharmacy, 2001
- Medication-Related Visits to the Emergency Department: A Prospective StudyAnnals of Pharmacotherapy, 1999
- Pharmacist Participation on Physician Rounds and Adverse Drug Events in the Intensive Care UnitJAMA, 1999
- Incidence of Adverse Drug Reactions in Hospitalized PatientsJAMA, 1998
- The Health Care Cost of Drug-Related Morbidity and Mortality in Nursing FacilitiesArchives of internal medicine (1960), 1997
- Drug-related illness in emergency department patientsAmerican Journal of Health-System Pharmacy, 1996
- Drug-Related Morbidity and MortalityArchives of internal medicine (1960), 1995
- Clinical Pharmacists Prescribing Drug Therapy in a Geriatric Setting: Outcome of a TrialJournal of the American Geriatrics Society, 1984